Could Radiomic Signature on Chest CT Predict Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer?

被引:1
|
作者
Cangir, Ayten Kayi [1 ]
Koksoy, Elif Berna [2 ]
Orhan, Kaan [3 ]
Ozakinci, Hilal [4 ]
Coruh, Aysegul Gursoy [5 ]
Gumustepe, Esra [6 ]
Kahya, Yusuf [1 ]
Ibrahimov, Farrukh [1 ]
Buyukceran, Emre Utkan [5 ]
Akyurek, Serap [5 ]
Sak, Serpil Dizbay [4 ]
机构
[1] Ankara Univ, Fac Med, Med Design Applicat & Res Ctr MEDITAM, Dept Thorac Surg, TR-06070 Ankara, Turkiye
[2] Ankara Univ, Fac Med, Dept Radiol, TR-06230 Ankara, Turkiye
[3] Ankara Univ, Fac Dent, Med Design Applicat & Res Ctr MEDITAM, TR-06070 Ankara, Turkiye
[4] Ankara Univ, Fac Med, Dept Pathol, TR-06070 Ankara, Turkiye
[5] Ankara Univ, Fac Med, Dept Radiol, TR-06070 Ankara, Turkiye
[6] Gulhane Training & Res Hosp, TR-06010 Ankara, Turkiye
来源
APPLIED SCIENCES-BASEL | 2024年 / 14卷 / 20期
关键词
lung cancer; <italic>EGFR</italic> mutation; biomarkers; computed tomography; radiomics; BIOPSY; HETEROGENEITY; OSIMERTINIB;
D O I
10.3390/app14209367
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Background: Detecting molecular drivers is crucial in the management of non-small-cell lung cancer (NSCLC). This study aimed to evaluate the use of pretreatment chest computed tomography (CT) radiomics features for predicting epidermal growth factor receptor (EGFR) mutation status in NSCLC. Materials and Methods: CT images were used to develop a radiomics-based model for predicting EGFR mutation status. Two different groups were formed from the dataset, namely groups for training (n = 380) and testing (n = 86). Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm on a radiomics platform. Machine learning methods were then applied to construct the radiomics models. Receiver operating characteristic curve analysis was conducted to assess the performance of the radiomics signature across different datasets and methods. Results: The frequency of EGFR mutation was 13.5% (58/430). A total of 1409 quantitative imaging features were extracted from CT images using the Radcloud platform. Among the six radiomics-based classifiers (k-Nearest Neighbor, Support Vector Machine (SVM), eXtreme Gradient Boosting, Random Forest, Logistic Regression, and Decision Tree), SVM demonstrated the highest area under the curve values in both the testing and training groups, reaching 0.87 and 0.98, respectively. Our model, which incorporated both clinical and radiomics data, successfully predicted EGFR mutation status with an accuracy rate of 86.9%. Conclusion: Our findings highlight the potential of radiomics features as a non-invasive predictive imaging biomarker for EGFR mutation status, which could enhance personalized treatment in NSCLC. Radiomics emerges as a valuable tool for identifying driver mutations, although further studies are necessary to validate its clinical utility in NSCLC.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to Osimertinib
    Bhuiyan, Sakil
    Siddiqui, Raheel S.
    Zirkiyeva, Milana
    Agladze, Mariam
    Bashir, Tayyaba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [42] Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer
    Zhu, Xinzhong
    Dong, Di
    Chen, Zhendong
    Fang, Mengjie
    Zhang, Liwen
    Song, Jiangdian
    Yu, Dongdong
    Zang, Yali
    Liu, Zhenyu
    Shi, Jingyun
    Tian, Jie
    EUROPEAN RADIOLOGY, 2018, 28 (07) : 2772 - 2778
  • [43] Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Mutation: First Line Treatment and Beyond
    Rocco, Danilo
    Battiloro, Ciro
    Della Gravara, Luigi
    Gridelli, Cesare
    REVIEWS ON RECENT CLINICAL TRIALS, 2019, 14 (02) : 120 - 128
  • [44] Analysis of tumor abnormal protein expression and epidermal growth factor receptor mutation status in non-small cell lung cancer
    Cheng, Yuanjun
    Chen, Bin
    Fang, Qianru
    Zang, Guohui
    Yao, Jie
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [45] Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
    Kensuke Kanaoka
    Hiromitsu Sumikawa
    Shunsuke Oyamada
    Akihiro Tamiya
    Yuji Inagaki
    Yoshihiko Taniguchi
    Keiko Nakao
    Yoshinobu Matsuda
    Kyoichi Okishio
    BMC Cancer, 23
  • [46] Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer
    Hata, Akito
    Yoshioka, Hiroshige
    Fujita, Shiro
    Kunimasa, Kei
    Kaji, Reiko
    Imai, Yukihiro
    Tomii, Keisuke
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Katakami, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1524 - 1528
  • [47] Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients
    Malapelle, Umberto
    Pilotto, Sara
    Reale, Maria Lucia
    Passiglia, Francesco
    Pisapia, Pasquale
    Pepe, Francesco
    Belluomini, Lorenzo
    Galetta, Domenico
    Cortinovis, Diego
    Tiseo, Marcello
    Passaro, Antonio
    Seminati, Davide
    Pagni, Fabio
    Parra, Hector Soto
    Migliorino, Maria Rita
    Rocco, Danilo
    Troncone, Giancarlo
    Novello, Silvia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 169
  • [48] A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma
    Lu, Xiaoqian
    Li, Mingyang
    Zhang, Huimao
    Hua, Shucheng
    Meng, Fanyang
    Yang, Hualin
    Li, Xueyan
    Cao, Dianbo
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (05)
  • [49] Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
    Ram, Aatma
    Siu, Chun T.
    Mukherjee, Abir
    Gupta, Ranju
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [50] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179